Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Bally's Corp Regulatory Filings 2022

Jul 27, 2022

32726_rns_2022-07-27_943d55d6-751e-4a9f-87d4-06accb1d92ac.zip

Regulatory Filings

Open in viewer

Opens in your device viewer

Field: Rule-Page

Field: /Rule-Page

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

Field: Rule-Page

Field: /Rule-Page

SCHEDULE TO

TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1) OF THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

Field: Rule-Page

Field: /Rule-Page

BALLY’S CORPORATION

(Name of Subject Company (Issuer) and Filing Person (Offeror))

Common Stock, Par Value $0.01 Per Share

(Title of Class of Securities)

05875B106

(CUSIP Number of Class of Securities)

Field: Rule-Page

Field: /Rule-Page

Robert Lavan Chief Financial Officer Bally’s Corporation 100 Westminster Street Providence, Rhode Island 02903 (401) 475-8474 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications on Behalf of Filing Person)

Field: Rule-Page

Field: /Rule-Page

Copy to:

Robert A. Profusek

Rory T. Hood Jones Day

250 Vesey Street New York, New York 10281 (212) 326-3939

Field: Rule-Page

Field: /Rule-Page

| ¨ Check
the box if the filing relates solely to preliminary communications made before the commencement of a tender offer. |
| --- |
| Check the appropriate boxes below to designate any transactions to which the statement relates: |
| ¨ third
party tender offer subject to Rule 14d-1. |
| x issuer
tender offer subject to Rule 13e-4. |
| ¨ going-private
transaction subject to Rule 13e-3. |
| ¨ amendment
to Schedule 13D under Rule 13d-2. |
| Check the following box if the filing is a final amendment reporting the results of the tender offer: x |
| If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon: |
| ¨ Rule 13e-4(i) (Cross-Border
Issuer Tender Offer) |
| ¨ Rule 14d-1(d) (Cross-Border
Third-Party Tender Offer) |

Field: Rule-Page

Field: /Rule-Page

Field: Page; Sequence: 1

Field: /Page

This Amendment No. 4 (this “Amendment”) amends and supplements the Tender Offer Statement on Schedule TO (the “Schedule TO”) originally filed with the Securities and Exchange Commission by Bally’s Corporation (“Bally’s”), on June 24, 2022, to purchase for cash its common shares, par value $0.01 per share (“Shares”), for an aggregate purchase price of not more than $190 million, at a per Share purchase price of not less than $19.25 nor greater than $22.00 per Share, on the terms and subject to the conditions described in the Offer to Purchase dated June 24, 2022 (the “Offer to Purchase”), a copy of which was filed as Exhibit (a)(1)(A) to the Schedule TO, and in the related Letter of Transmittal (the “Letter of Transmittal” and, together with the Offer to Purchase, as they may be amended or supplemented from time to time, the “Offer”), a copy of which was filed as Exhibit (a)(1)(B) to the Schedule TO.

This Amendment amends and supplements the Schedule TO. Only items amended or supplemented are reported in this Amendment and except as provided herein, the information contained in the Schedule TO remains unchanged.

Item 11. Additional Information.

Item 11 of the Schedule TO is hereby amended and supplemented as follows:

On July 27, 2022, Bally’s issued a press release announcing the final results of the Offer, which expired at 12:00 midnight, New York City time, at the end of the day on July 22, 2022. A copy of such press release is filed as Exhibit (a)(5)(D) hereto and is incorporated by reference into Item 11 of this Schedule TO.

Item 12. Exhibits.

Item 12 of the Schedule TO is hereby amended and supplemented by adding the following exhibit:

Exhibit Number Description
(a)(5)(D) Press Release dated July 27, 2022*

Field: Rule-Page

Field: /Rule-Page

*Filed herewith.

Field: Page; Sequence: 2; Options: NewSection; Value: 2

Field: Sequence; Type: Arabic; Name: PageNo 2 Field: /Sequence

Field: /Page

SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BALLY’S CORPORATION
By: /s/ Robert M. Lavan
Robert M. Lavan
Chief Financial Officer
Date: July 27, 2022

Field: Page; Sequence: 3; Options: Last

Field: Sequence; Type: Arabic; Name: PageNo 3 Field: /Sequence

Field: /Page